Product Detail

Masimo carbon oxygen oximeter adopts advanced Masimo SET technology to screen neonatal congenital heart disease by monitoring SpO2 (blood oxygen saturation) of newborns and draw conclusions.
The role of SpO2 in neonatal monitoring:

• It is used for strict oxygen inhalation treatment and accurate pulse and blood oxygen monitoring to reduce the recurrence of hyperoxia and hypooxia, reduce the incidence of severe neonatal retinopathy (ROP), and also reduce the rate of false alarm
• It is used to monitor severe neonatal diseases such as left atrial hypoplasia
• It is used for cyanotic congenital heart disease patients and screening for congenital heart disease
• Used for nursing monitoring of patients with low perfusion during special period

Why neonatal screening is necessary
As we all know, the incidence of congenital heart disease is about 1%, of which 1/3 is severe congenital heart disease. Severe congenital heart disease includes two categories: one is critical congenital heart disease, which will die if not intervened in the neonatal period; The other is severe congenital heart disease, which will also die if not intervened within 1 year old.
The purpose of neonatal screening is to detect severe congenital heart disease at an early stage. Research in western countries shows that if screening is not carried out, the missed diagnosis rate of neonatal critical congenital heart disease before delivery can reach 30%. Delayed diagnosis led to a neonatal mortality rate of 38.8% and a mortality rate of 50.6% at 3 months, while timely diagnosis reduced the mortality rate to 20% at 3 months.
How to perform neonatal screening
The neonatal congenital heart screening should be completed within 24-48 hours after birth. If it is found that the blood oxygen is low and does not recover within 24 hours after birth (the blood oxygen saturation of normal newborns can reach 85~95% within 10 minutes after birth), the color Doppler echocardiography can be carried out at an early stage to find out whether there is a heart problem as soon as possible, which will help the clinical diagnosis.
Newborn congenital heart disease screening objects: newborns 24-48 hours after birth
Measurement position of neonatal congenital heart screening: right hand or any foot of the measuring object
Newborn congenital heart screening parameters: SpO2 (blood oxygen saturation), PI (blood perfusion index)
Newborn congenital heart screening steps:

1. Step 1: In front of the catheter (right hand)
   Place the sensor on the outer side of the right hand, under the fourth or fifth finger, wrap the detection part with tape, and ensure that the transmitter is aligned with the detector

2. Step 2: Record SpO2 and PI
3. Step 3: Behind the catheter (left or right foot)
   Place the sensor on the outer side of one foot, under the fourth and fifth toes, wrap the detection part with tape, and ensure that the transmitter and detector are aligned

4. Step 4: Record SpO2 and PI
5. Step 5: CCHD screening results